The Brokers Offer Predictions for Tonix Pharmaceuticals Holding Corp.’s FY2019 Earnings (TNXP)

The Brokers Offer Predictions for Tonix Pharmaceuticals Holding Corp.’s FY2019 Earnings (TNXP)

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) – Equities research analysts at Oppenheimer Holdings issued their FY2019 earnings per share (EPS) estimates for shares of Tonix Pharmaceuticals Holding Corp. in a research report issued on Monday. Oppenheimer Holdings analyst J. Olson forecasts that the brokerage will post earnings per share of ($1.03) for the year. Oppenheimer Holdings has a “Market Perform” rating on the stock. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) last announced its quarterly earnings results on Thursday, November 10th. The company reported ($0.29) EPS for the quarter, beating the Zacks’ consensus…

The Equities Analysts Offer Predictions for AveXis Inc.’s FY2019 Earnings (AVXS)

The Equities Analysts Offer Predictions for AveXis Inc.’s FY2019 Earnings (AVXS)

AveXis Inc. (NASDAQ:AVXS) – Investment analysts at Jefferies Group dropped their FY2019 earnings estimates for shares of AveXis in a report released on Monday. Jefferies Group analyst B. Amin now expects that the brokerage will post earnings of $2.94 per share for the year, down from their previous forecast of $3.38. Jefferies Group has a “Buy” rating and a $79.00 price objective on the stock. Jefferies Group also issued estimates for AveXis’ FY2020 earnings at $6.86 EPS. AveXis (NASDAQ:AVXS) last announced its quarterly earnings data on Thursday, November 10th. The…

The Research Analysts Issue Forecasts for Cardiovascular Systems Inc.’s FY2019 Earnings (CSII)

The Research Analysts Issue Forecasts for Cardiovascular Systems Inc.’s FY2019 Earnings (CSII)

Cardiovascular Systems Inc. (NASDAQ:CSII) – Research analysts at Leerink Swann issued their FY2019 earnings per share (EPS) estimates for shares of Cardiovascular Systems in a research report issued on Tuesday. Leerink Swann analyst D. Antalffy forecasts that the firm will earn $0.25 per share for the year. Leerink Swann currently has a “Outperform” rating and a $30.00 price objective on the stock. Several other equities research analysts also recently commented on CSII. Bank of America Corp. raised shares of Cardiovascular Systems from an “underperform” rating to a “neutral” rating in…

The Brokers Issue Forecasts for The Laclede Group Inc.’s FY2019 Earnings (SR)

The Brokers Issue Forecasts for The Laclede Group Inc.’s FY2019 Earnings (SR)

The Laclede Group Inc. (NYSE:SR) – Equities researchers at Gabelli cut their FY2019 EPS estimates for The Laclede Group in a research report issued on Wednesday. Gabelli analyst T. Winter now anticipates that the brokerage will post earnings per share of $3.90 for the year, down from their previous forecast of $3.95. Gabelli also issued estimates for The Laclede Group’s FY2020 earnings at $4.05 EPS. The Laclede Group (NYSE:SR) last released its quarterly earnings results on Tuesday, November 15th. The company reported ($0.32) EPS for the quarter, hitting the consensus…

The 2,000 Shares of Stock are sold by Ciena Corp. (CIEN) VP James Frodsham

The 2,000 Shares of Stock are sold by Ciena Corp. (CIEN) VP James Frodsham

Ciena Corp. (NYSE:CIEN) VP James Frodsham sold 2,000 shares of Ciena Corp. stock in a transaction that occurred on Tuesday, November 15th. The stock was sold at an average price of $22.40, for a total value of $44,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. James Frodsham also recently made the following trade(s): On Monday, November 14th, James Frodsham sold 2,000 shares of Ciena Corp. stock. The stock was sold at an average price of $22.21,…

The 1,054 Shares of Stock are sold by GrubHub Inc (GRUB) SVP Margo Drucker

The 1,054 Shares of Stock are sold by GrubHub Inc (GRUB) SVP Margo Drucker

GrubHub Inc (NASDAQ:GRUB) SVP Margo Drucker sold 1,054 shares of the firm’s stock in a transaction dated Tuesday, November 15th. The shares were sold at an average price of $36.62, for a total value of $38,597.48. Following the completion of the sale, the senior vice president now owns 1,554 shares of the company’s stock, valued at $56,907.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Margo Drucker also recently made the following trade(s): On Friday, October 14th, Margo Drucker sold…

The Texas Permanent School Fund reduces its investment in Hancock Holding Co. (HBHC)

The Texas Permanent School Fund reduces its investment in Hancock Holding Co. (HBHC)

Texas Permanent School Fund reduced its stake in Hancock Holding Co. (NASDAQ:HBHC) by 0.3% during the third quarter, Holdings Channel reports. The firm owned 59,072 shares of the financial services provider’s stock after selling 197 shares during the period. Texas Permanent School Fund owned about 0.08% of Hancock Holding worth $1,916,000 as of its most recent SEC filing. Several other large investors have also recently modified their holdings of the company. Public Employees Retirement System of Ohio raised its position in Hancock Holding by 8.5% in the second quarter. Public…

The Texas Permanent School Fund invests in Texas Roadhouse Inc. (TXRH) Shares

The Texas Permanent School Fund invests in Texas Roadhouse Inc. (TXRH) Shares

Texas Permanent School Fund increased its position in Texas Roadhouse Inc. (NASDAQ:TXRH) by 0.9% during the third quarter, Holdings Channel reports. The firm owned 48,831 shares of the company’s stock after buying an additional 439 shares during the period. Texas Permanent School Fund owned about 0.07% of Texas Roadhouse worth $1,906,000 as of its most recent SEC filing. Several other hedge funds also recently bought and sold shares of the company. Van Hulzen Asset Management LLC bought a new stake in Texas Roadhouse during the second quarter worth about $102,000….

The Texas Permanent School Fund Raises Stake in Integra LifeSciences Holdings Corp. (IART)

The Texas Permanent School Fund Raises Stake in Integra LifeSciences Holdings Corp. (IART)

Texas Permanent School Fund boosted its position in shares of Integra LifeSciences Holdings Corp. (NASDAQ:IART) by 2.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,769 shares of the company’s stock after buying an additional 572 shares during the period. Texas Permanent School Fund owned 0.06% of Integra LifeSciences Holdings Corp. worth $1,880,000 at the end of the most recent quarter. Other large investors have also recently made changes to their positions in the company. BlackRock Inc. raised…

The Raab & Moskowitz Asset Management LLC Buys 511 Shares of Wal-Mart Stores Inc. (WMT)

The Raab & Moskowitz Asset Management LLC Buys 511 Shares of Wal-Mart Stores Inc. (WMT)

Raab & Moskowitz Asset Management LLC boosted its stake in Wal-Mart Stores Inc. (NYSE:WMT) by 7.5% during the third quarter, Holdings Channel reports. The institutional investor owned 7,294 shares of the retailer’s stock after buying an additional 511 shares during the period. Raab & Moskowitz Asset Management LLC’s holdings in Wal-Mart Stores were worth $526,000 as of its most recent SEC filing. Several other institutional investors have also recently added to or reduced their stakes in WMT. Panagora Asset Management Inc. raised its position in shares of Wal-Mart Stores by…

The Heron Therapeutics Inc. to Post FY2019 Earnings of $1.04 Per Share, Leerink Swann Forecasts (HRTX)

The Heron Therapeutics Inc. to Post FY2019 Earnings of $1.04 Per Share, Leerink Swann Forecasts (HRTX)

Heron Therapeutics Inc. (NASDAQ:HRTX) – Analysts at Leerink Swann decreased their FY2019 EPS estimates for Heron Therapeutics in a research note issued to investors on Tuesday. Leerink Swann analyst J. Gerberry now anticipates that the brokerage will earn $1.04 per share for the year, down from their previous forecast of $1.07. Leerink Swann currently has a “Buy” rating and a $34.00 target price on the stock. Heron Therapeutics (NASDAQ:HRTX) last released its earnings results on Tuesday, November 8th. The biotechnology company reported ($1.24) earnings per share (EPS) for the quarter,…

The Equitable Group Inc. (EQB) Stock Rating Reaffirm by Scotiabank

The Equitable Group Inc. (EQB) Stock Rating Reaffirm by Scotiabank

Equitable Group Inc. (TSE:EQB)‘s stock had its “sector perform” rating restated by equities research analysts at Scotiabank in a note issued to investors on Thursday. They presently have a C$69.00 target price on the stock. Scotiabank’s price objective would suggest a potential upside of 28.47% from the stock’s current price. EQB has been the topic of several other reports. National Bank Financial upped their price target on shares of Equitable Group from C$70.00 to C$74.00 and gave the company an “outperform” rating in a report on Monday, August 15th. TD…

The DREAM Unlimited Corp (DRM) PT Decreased to C$10.00 at CIBC

The DREAM Unlimited Corp (DRM) PT Decreased to C$10.00 at CIBC

DREAM Unlimited Corp (TSE:DRM) had its price objective lowered by investment analysts at CIBC from C$10.75 to C$10.00 in a report released on Thursday. CIBC’s price target would suggest a potential upside of 48.37% from the stock’s current price. Separately, TD Securities raised their price target on shares of DREAM Unlimited Corp from C$9.00 to C$15.00 and gave the stock a “hold” rating in a research note on Friday, September 9th. Shares of DREAM Unlimited Corp (TSE:DRM) traded up 1.04% on Thursday, hitting $6.81. 40,800 shares of the company were…

The Dream Global REIT (DRG.UN) Price Target Increased to C$9.30 by Analysts at CIBC

The Dream Global REIT (DRG.UN) Price Target Increased to C$9.30 by Analysts at CIBC

Dream Global REIT (TSE:DRG.UN) had its target price upped by equities research analysts at CIBC from C$9.00 to C$9.30 in a research report issued to clients and investors on Thursday. A number of other equities analysts have also commented on DRG.UN. National Bank Financial reissued an “outperform” rating and issued a C$9.75 price objective on shares of Dream Global REIT in a research note on Monday, August 8th. TD Securities reaffirmed a “buy” rating and set a C$10.00 price target on shares of Dream Global REIT in a research note…

The Centerra Gold’s (CG) “Sector Perform” Rating Reiterate at Scotiabank

The Centerra Gold’s (CG) “Sector Perform” Rating Reiterate at Scotiabank

Centerra Gold Inc. (TSE:CG)‘s stock had its “sector perform” rating reaffirmed by equities researchers at Scotiabank in a report released on Thursday. They presently have a C$8.00 price target on the stock. Scotiabank’s target price suggests a potential upside of 16.45% from the company’s current price. CG has been the topic of a number of other reports. Canaccord Genuity raised their price objective on Centerra Gold from C$8.50 to C$8.75 and gave the company a “buy” rating in a research note on Monday, October 24th. Royal Bank Of Canada reaffirmed…

The Harvard Bioscience Inc. (HBIO) Coverage Initiated at Singular Research

The Harvard Bioscience Inc. (HBIO) Coverage Initiated at Singular Research

Equities research analysts at Singular Research assumed coverage on shares of Harvard Bioscience Inc. (NASDAQ:HBIO) in a report issued on Thursday. The firm set a “buy” rating and a $5.50 price target on the stock. Singular Research’s target price would indicate a potential upside of 111.54% from the company’s previous close. Separately, Zacks Investment Research lowered shares of Harvard Bioscience from a “hold” rating to a “sell” rating in a research report on Tuesday, August 2nd. Shares of Harvard Bioscience (NASDAQ:HBIO) traded down 1.92% during trading on Thursday, reaching $2.55….

The Best Buy Co. (BBY) Upgrade to Neutral by Bank of America Corp.

The Best Buy Co. (BBY) Upgrade to Neutral by Bank of America Corp.

Best Buy Co. (NYSE:BBY) was upgraded by equities research analysts at Bank of America Corp. from an “underperform” rating to a “neutral” rating in a report issued on Thursday. Other equities analysts also recently issued research reports about the stock. Barclays PLC reaffirmed a “buy” rating and issued a $45.00 price objective on shares of Best Buy in a report on Tuesday, August 23rd. Wedbush reaffirmed a “buy” rating and issued a $20.50 price objective on shares of Best Buy in a report on Wednesday, August 17th. BTIG Research reaffirmed…

The FY2018 EPS Estimates for Citizens Financial Group Inc. (CFG) Raised by Analyst

The FY2018 EPS Estimates for Citizens Financial Group Inc. (CFG) Raised by Analyst

Citizens Financial Group Inc. (NYSE:CFG) – Stock analysts at Wedbush increased their FY2018 earnings estimates for Citizens Financial Group in a research note issued to investors on Monday. Wedbush analyst now anticipates that the firm will post earnings of $2.39 per share for the year, up from their prior estimate of $2.37. Wedbush has a “Neutral” rating and a $31.00 price target on the stock. Citizens Financial Group (NYSE:CFG) last announced its quarterly earnings data on Friday, October 21st. The company reported $0.52 earnings per share (EPS) for the quarter,…